Partner Headlines - BMY

  1. Bristol-Myers Squibb to Host Investor Teleconference to Discuss ...

    Benzinga
  2. U.S. Food and Drug Administration Accepts for Priority Review ...

    Benzinga
  3. Benzinga's M&A Chatter for Thursday August 27, 2015

    Benzinga
  4. Allied-Bristol Life Sciences Licenses Platform Technology and ...

    Benzinga
  5. Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

    GuruFocus
  6. uniQure Receives Additional $53M from Bristol-Myers Squibb for ...

    Benzinga
  7. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD
  8. Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal

    IBD
  9. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD
  10. Valeant Posts Princely Gains

    IBD
  11. Bristol-Myers Q2 profit jumps

    IBD
  12. 3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates

    IBD
  13. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD
  14. Lilly, Bristol-Myers Beat Q2 Views, Lift Guidance

    IBD
  15. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD
  16. Bristol-Myers Squibb Posts Upbeat Q2 Results, Lifts Profit Forecast

    Benzinga
  17. Stock Futures Up, But Volatile; SanDisk, Cirrus, Fortinet Soar

    IBD
  18. US Stock Futures Rise Ahead Of General Motors, McDonald's Earnings

    Benzinga
  19. European Medicines Agency Validates Two Parallel Type II Variation ...

    Benzinga
  20. Bristol Myers Announces EMA Validates Two Parallel Type II Variation ...

    Benzinga
  21. Earnings Scheduled For July 23, 2015

    Benzinga
  22. Second-Generation Investigational HIV-1 Maturation Inhibitor ...

    Benzinga
  23. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD
  24. Bristol-Myers: kidney drug win

    IBD
  25. Bristol-Myers Announces European Commission Has Approved Nivolumab ...

    Benzinga
  26. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD
  27. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD
  28. Bristol-Myers' HIV-1 Drug Approved In Europe

    Benzinga
  29. What Will Gilead Buy Next? 4 Possible Targets

    IBD
  30. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga
  31. Fast Money Picks For July 7

    Benzinga
  32. Biogen, AGTC Link Up To Develop Gene Therapy

    IBD
  33. Can Hepatitis B Be A Blockbuster Bug?

    IBD
  34. Amgen Among 3 Medical Giants With Healthy Payouts

    IBD
  35. Will Bill Ackman Go After Express Scripts Next?

    GuruFocus
  36. Fast Money Picks For June 30

    Benzinga
  37. Aetna Said Close To Humana Deal; Kroger Ups Dividend

    IBD
  38. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The ...

    GuruFocus
  39. Benzinga's Top Initiations

    Benzinga
  40. Piper Jaffray Initiates Bristol-Myers Squibb With Underperform

    Benzinga
  41. Axovant Sciences Sets 20-Year Record For Biotech IPOs

    IBD
  42. What We Don't Know About Antibiotics Could Kill Us

    FoxBusiness
  43. 2 M&A Rumors Moving The Market

    Benzinga
  44. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD
  45. Stocks Protect Solid Gains; Bullish Setup For Zebra Technologies

    IBD
  46. Stocks Eke Out Narrow Gains; eBay Breakout Gains Traction

    IBD
  47. Options Outlook: Market Switches From 'Headline' To 'Sentiment' ...

    Benzinga
  48. 4 Stocks Rising On ASCO Cancer Drug News

    IBD
  49. Stocks Step Out To Mixed Start; Bristol Myers Rises, Wynn Fades

    IBD
  50. Bristol Dives On Cancer Drug

    IBD
  51. Stocks End On A Downer; Oil Jumps, Selling Resumes In Chipotle

    IBD
  52. Bristol Sinks On Lung Cancer Data; Merck Up On 2 Trials

    IBD
  53. Fast Money Picks For May 27

    Benzinga
  54. Merck got EU's CHMP

    IBD
  55. Puma Crashes, Roche Rises On Cancer Data News

    IBD
  56. Berenberg Initiates Bristol-Myers Squibb With Hold

    Benzinga
  57. Benzinga's Top Initiations

    Benzinga
  58. Benzinga's Top #PreMarket Losers

    Benzinga
  59. Bristol-Myers Squibb to Present Data at 2015 American Society ...

    Benzinga
  60. Making Money With Charles Payne: 05/8/15

    FoxBusiness
  61. Bayer Enters Into Collaboration With Isis For Enhancing Its Drug ...

    GuruFocus
  62. Merck's Stock Price, Dividend Yield Beating S&P 500

    IBD
  63. Bristol-Myers Squibb

    IBD
  64. Vanguard Adds to Four of Its Largest Stakes

    GuruFocus
  65. Merck Jumps, United Therapeutics Drops On Q1 Earnings

    IBD
  66. Merck Up On Q1, Januvia Report; Bristol, Pfizer Mixed

    IBD
  67. Stock Futures Mixed, Nasdaq Up; Apple, Vasco, Merck Rising

    IBD
  68. Earnings Scheduled For April 28, 2015

    Benzinga
  69. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD
  70. 4 Drug Giants Reporting Earnings This Week

    IBD
  71. Benzinga's Weekend M&A Chatter

    Benzinga
  72. U.S. Tech, Dollar & Health Care ETFs To Watch This Week

    Benzinga
  73. Benzinga's Top Upgrades

    Benzinga
  74. Cancer Drugs Impress Again

    IBD
  75. CAR-T Therapy Stocks Hit Hard Following AACR Data

    Benzinga
  76. Bristol, Merck Cancer Drugs Strut Their Stuff

    IBD
  77. Bristol-Myers scores again

    IBD
  78. It's A Big Weekend For Biotech

    Benzinga
  79. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD
  80. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD
  81. Bristol-Myers Up Big After Drug Study Stopped Early

    Benzinga
  82. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD
  83. Benzinga's M&A Chatter for Monday April 13, 2015

    Benzinga
  84. Bristol-Myers Squibb Canada Announces Hepatitis C Cure Rate of ...

    Benzinga
  85. UPDATE: USDA Approves Supplimental Biologics License

    Benzinga
  86. USDA Accepts Supplemental Biologics License Application for Yervoy ...

    Benzinga
  87. Bristol Myers Reports Data Supporting Clinical Development Of ...

    Benzinga
  88. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD
  89. Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug

    Benzinga
  90. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD
  91. Bristol-Myers goes for the gut

    IBD
  92. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD
  93. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals ...

    GuruFocus
  94. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD
  95. Morning Market Gainers

    Benzinga
  96. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  97. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative ...

    Benzinga
  98. Strong Dollar Weakens Views

    IBD
  99. Drugmakers Warn On Dollar

    IBD
  100. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!